| 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus M Aringer, K Costenbader, D Daikh, R Brinks, M Mosca, ... Arthritis & rheumatology 71 (9), 1400-1412, 2019 | 2630 | 2019 |
| Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis RB Jones, JW Cohen Tervaert, T Hauser, R Luqmani, MD Morgan, ... New England Journal of Medicine 363 (3), 211-220, 2010 | 1960 | 2010 |
| 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus A Fanouriakis, M Kostopoulou, A Alunno, M Aringer, I Bajema, JN Boletis, ... Annals of the rheumatic diseases 78 (6), 736-745, 2019 | 1756 | 2019 |
| A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies D Jayne, N Rasmussen, K Andrassy, P Bacon, JWC Tervaert, ... New England Journal of Medicine 349 (1), 36-44, 2003 | 1671 | 2003 |
| EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis M Yates, RA Watts, IM Bajema, MC Cid, B Crestani, T Hauser, B Hellmich, ... Annals of the rheumatic diseases 75 (9), 1583-1594, 2016 | 1336 | 2016 |
| Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis DRW Jayne, G Gaskin, N Rasmussen, D Abramowicz, F Ferrario, ... Journal of the American Society of Nephrology 18 (7), 2180-2188, 2007 | 1327 | 2007 |
| Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis GB Appel, G Contreras, MA Dooley, EM Ginzler, D Isenberg, D Jayne, ... Journal of the American Society of Nephrology 20 (5), 1103-1112, 2009 | 1276 | 2009 |
| EULAR recommendations for the management of primary small and medium vessel vasculitis C Mukhtyar, L Guillevin, MC Cid, B Dasgupta, K de Groot, W Gross, ... Annals of the rheumatic diseases 68 (3), 310-317, 2009 | 1275 | 2009 |
| Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of … GK Bertsias, M Tektonidou, Z Amoura, M Aringer, I Bajema, JHM Berden, ... Annals of the rheumatic diseases 71 (11), 1771-1782, 2012 | 1227 | 2012 |
| Modification and validation of the Birmingham Vasculitis Activity Score (version 3) C Mukhtyar, R Lee, D Brown, D Carruthers, B Dasgupta, S Dubey, ... Annals of the rheumatic diseases 68 (12), 1827-1832, 2009 | 1143 | 2009 |
| Genetically distinct subsets within ANCA-associated vasculitis PA Lyons, TF Rayner, S Trivedi, JU Holle, RA Watts, DRW Jayne, ... New England Journal of Medicine 367 (3), 214-223, 2012 | 1064 | 2012 |
| Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody—associated vasculitis: a randomized trial K De Groot, L Harper, DRW Jayne, LF Flores Suarez, G Gregorini, ... Annals of internal medicine 150 (10), 670-680, 2009 | 1033 | 2009 |
| Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis K De Groot, N Rasmussen, PA Bacon, JWC Tervaert, C Feighery, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2005 | 973 | 2005 |
| Long-term patient survival in ANCA-associated vasculitis O Flossmann, A Berden, K de Groot, C Hagen, L Harper, C Heijl, ... Annals of the rheumatic diseases 70 (3), 488-494, 2011 | 957 | 2011 |
| Histopathologic classification of ANCA-associated glomerulonephritis AE Berden, F Ferrario, EC Hagen, DR Jayne, JC Jennette, K Joh, ... Journal of the American Society of Nephrology 21 (10), 1628-1636, 2010 | 927 | 2010 |
| EULAR recommendations for the management of large vessel vasculitis C Mukhtyar, L Guillevin, MC Cid, B Dasgupta, K de Groot, W Gross, ... Annals of the rheumatic diseases 68 (3), 318-323, 2009 | 843 | 2009 |
| Antineutrophil cytoplasmic antibodies and the Churg–Strauss syndrome R Sablé-Fourtassou, P Cohen, A Mahr, C Pagnoux, L Mouthon, D Jayne, ... Annals of internal medicine 143 (9), 632-638, 2005 | 837 | 2005 |
| Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis ME Wechsler, P Akuthota, D Jayne, P Khoury, A Klion, CA Langford, ... New England Journal of Medicine 376 (20), 1921-1932, 2017 | 817 | 2017 |
| KDIGO 2021 clinical practice guideline for the management of glomerular diseases BH Rovin, SG Adler, J Barratt, F Bridoux, KA Burdge, TM Chan, HT Cook, ... Kidney international 100 (4), S1-S276, 2021 | 801 | 2021 |
| Treat-to-target in systemic lupus erythematosus: recommendations from an international task force RF Van Vollenhoven, M Mosca, G Bertsias, D Isenberg, A Kuhn, ... Annals of the rheumatic diseases 73 (6), 958-967, 2014 | 795 | 2014 |
Peter MerkelVerified email at upenn.edu
